MicroRNA-139-5p acts as a suppressor gene for depression by targeting nuclear receptor subfamily 3, group C, member 1.
BDNF-TrkB signaling pathway
NR3C1
depression
miR-139-5p
Journal
Bioengineered
ISSN: 2165-5987
Titre abrégé: Bioengineered
Pays: United States
ID NLM: 101581063
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
entrez:
11
5
2022
pubmed:
12
5
2022
medline:
14
5
2022
Statut:
ppublish
Résumé
MicroRNA-139-5p (miR-139-5p) is one of the most differentially expressed miRNAs in the brain between healthy people and depressed patients. However, its function in depression is unclear. Therefore, we investigated the function of miR-139-5p in depression. Here, miR-139-5p expression was found to be upregulated in the model group. MiR-139-5p inhibition could increase sucrose preference and decrease mice immobility time after chronic corticosterone (CORT) injection. Furthermore, compared with the antago-NC group, 3 weeks of antagomiR-139-5p treatment significantly decreased miR-139-5p level in model group hippocampus, increased sucrose preference index, reduced neuron damages, and enhanced the levels of nuclear receptor subfamily 3 group C member 1 (NR3C1), brain-derived neurotrophic factor (BDNF), phosphorylated/total tyrosine kinase receptor B (p-TrkB/TrkB), phosphorylated/total cAMP-response element-binding protein (p-CREB/CREB) and phosphorylated/total extracellular regulated protein kinases (p-ERK/ERK). Moreover, as a potential target for miR-139-5p, NR3C1 level was reduced by miR-139-5p mimic. Altogether, by activating the BDNF-TrkB signaling pathway, miR-139-5p inhibition plays an antidepressant-like role and might serve as an effective depression target (Fig. graphical abstract).
Identifiants
pubmed: 35543383
doi: 10.1080/21655979.2022.2059937
pmc: PMC9276025
doi:
Substances chimiques
Brain-Derived Neurotrophic Factor
0
MIRN139 microRNA, human
0
MIRN139 microRNA, mouse
0
MicroRNAs
0
Sucrose
57-50-1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
11856-11866Références
Ann Transl Med. 2021 Oct;9(20):1594
pubmed: 34790800
PLoS One. 2018 Jun 7;13(6):e0198429
pubmed: 29879167
Science. 2017 Sep 22;357(6357):
pubmed: 28798046
Cell Death Dis. 2018 Jan 5;9(1):3
pubmed: 29305594
Med Sci Sports Exerc. 2019 Jun;51(6):1162-1168
pubmed: 30694979
PLoS One. 2017 Jul 31;12(7):e0181961
pubmed: 28759626
Health Aff (Millwood). 1999 Sep-Oct;18(5):163-71
pubmed: 10495604
Pharmacol Biochem Behav. 2014 May;120:140-8
pubmed: 24631486
J Cell Sci. 2018 Feb 21;131(4):
pubmed: 29467236
Cell Stress Chaperones. 2019 Jul;24(4):719-733
pubmed: 31134533
Oncol Lett. 2017 Aug;14(2):1215-1222
pubmed: 28789336
Biochem Biophys Res Commun. 2017 Mar 25;485(1):167-173
pubmed: 28202414
J Oral Pathol Med. 2018 Mar;47(3):221-227
pubmed: 28650560
Oncotarget. 2017 Jul 11;8(28):46006-46019
pubmed: 28545018
Clin Transl Gastroenterol. 2019 Jan;10(1):e00003
pubmed: 30702491
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):417-425
pubmed: 28764913
Science. 2014 Sep 19;345(6203):1494-8
pubmed: 25237099
Biomark Cancer. 2017 Jan 09;9:1-8
pubmed: 28096697
Bioengineered. 2021 Dec;12(2):11520-11532
pubmed: 34889698
Semin Cancer Biol. 2017 Oct;46:146-157
pubmed: 28185862
Sci Rep. 2017 Jun 29;7(1):4387
pubmed: 28663595
BMC Psychiatry. 2019 Feb 1;19(1):52
pubmed: 30709391
Brain Res Bull. 2021 Apr;169:73-80
pubmed: 33400954
J Biomed Inform. 2019 Jun;94:103180
pubmed: 31039404
Int J Neuropsychopharmacol. 2017 Jun 1;20(6):485-497
pubmed: 28339691
Neurochem Int. 2012 Jun;60(8):743-50
pubmed: 22465943
Neurotox Res. 2018 Oct;34(3):489-510
pubmed: 29736827
Sci Rep. 2017 Mar 06;7:43393
pubmed: 28262692
Evid Based Complement Alternat Med. 2017;2017:7903918
pubmed: 28694833
Clin Epigenetics. 2015 Jul 22;7:69
pubmed: 26199675
Psychol Med. 2019 Mar;49(4):655-663
pubmed: 29903051
Brain Res. 2014 Aug 19;1577:69-76
pubmed: 24997248
Neuropsychiatr Dis Treat. 2020 Nov 10;16:2689-2693
pubmed: 33204094
Am J Psychiatry. 2018 Apr 1;175(4):327-335
pubmed: 29202655
Neural Plast. 2017;2017:6871089
pubmed: 28246558
Biomed Res Int. 2018 May 20;2018:4149707
pubmed: 29888262
Front Plant Sci. 2017 Nov 21;8:1943
pubmed: 29209340
Oncotarget. 2017 Mar 28;8(13):21187-21199
pubmed: 28177900
Thorac Cancer. 2017 Sep;8(5):461-470
pubmed: 28660665
Neuropsychopharmacology. 2020 May;45(6):1050-1058
pubmed: 31986519
Science. 2017 Feb 10;355(6325):634-637
pubmed: 28183980